- Home
- CIX vs ITOS Comparison
CIX vs ITOS Comparison
Compare CIX & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- ITOS
- Stock Information
- Founded
- CIX 1993
- ITOS 2011
- Country
- CIX United States
- ITOS United States
- Employees
- CIX N/A
- ITOS N/A
- Industry
- CIX Industrial Machinery/Components
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIX Consumer Discretionary
- ITOS Health Care
- Exchange
- CIX Nasdaq
- ITOS Nasdaq
- Market Cap
- CIX N/A
- ITOS 270.7M
- IPO Year
- CIX 1998
- ITOS 2020
- Fundamental
- Price
- CIX $22.77
- ITOS $6.64
- Analyst Decision
- CIX
- ITOS Strong Buy
- Analyst Count
- CIX 0
- ITOS 3
- Target Price
- CIX N/A
- ITOS $26.00
- AVG Volume (30 Days)
- CIX 7.9K
- ITOS 403.1K
- Earning Date
- CIX 03-05-2025
- ITOS 03-05-2025
- Dividend Yield
- CIX 5.30%
- ITOS N/A
- EPS Growth
- CIX N/A
- ITOS N/A
- EPS
- CIX 1.35
- ITOS N/A
- Revenue
- CIX $145,941,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CIX N/A
- ITOS N/A
- Revenue Next Year
- CIX N/A
- ITOS $121.70
- P/E Ratio
- CIX $16.46
- ITOS N/A
- Revenue Growth
- CIX N/A
- ITOS 177.89
- 52 Week Low
- CIX $20.60
- ITOS $6.67
- 52 Week High
- CIX $37.91
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- CIX 43.22
- ITOS 39.03
- Support Level
- CIX $21.65
- ITOS $6.72
- Resistance Level
- CIX $22.55
- ITOS $7.05
- Average True Range (ATR)
- CIX 0.99
- ITOS 0.32
- MACD
- CIX 0.09
- ITOS -0.03
- Stochastic Oscillator
- CIX 50.28
- ITOS 1.61
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.